CYTOKINETICS, INCORPORATED (CYTK) Total liabilities 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) total liabilities at each fiscal year-end, per SEC filings.
$2.1BFY2025 · since FY2016: $75.8M → $2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1B | +35.6% |
| FY2024 | $1.5B | +27.0% |
| FY2023 | $1.2B | +7.8% |
| FY2022 | $1.1B | +87.9% |
| FY2021 | $597.5M | +42.1% |
| FY2020 | $420.4M | +39.8% |
| FY2019 | $300.8M | +62.4% |
| FY2018 | $185.2M | +0.1% |
| FY2017 | $185.0M | +144.1% |
| FY2016 | $75.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTK financial trends
CYTK RevenueCYTK Net incomeCYTK Net marginCYTK Gross profitCYTK Gross marginCYTK Operating incomeCYTK Operating marginCYTK Operating cash flowCYTK Free cash flowCYTK Capital expendituresCYTK Return on equityCYTK Stock buybacksCYTK Dividends paidCYTK Total assetsCYTK Shareholders’ equityCYTK overview →